Strength
75 mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597035509
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA022512On Market Since
8/8/2011
Pharmacological Classes
Direct Thrombin Inhibitor
Thrombin Inhibitors
Related Drugs
Same classification
No related drugs found.